Detalhe da pesquisa
1.
Next-Generation Sequencing of Minimal Residual Disease for Predicting Relapse after Tisagenlecleucel in Children and Young Adults with Acute Lymphoblastic Leukemia.
Blood Cancer Discov
; 3(1): 66-81, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35019853
2.
Tisagenlecleucel immunogenicity in relapsed/refractory acute lymphoblastic leukemia and diffuse large B-cell lymphoma.
Blood Adv
; 5(23): 4980-4991, 2021 12 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34432863